Your session is about to expire
← Back to Search
Behavioural Intervention
Robotic Training with Auditory Feedback for Cerebral Palsy
N/A
Waitlist Available
Led By Jiyeon Kang
Research Sponsored by State University of New York at Buffalo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ambulation of a distance of 100 feet with or without the use of assistive devices.
Adults with cerebral palsy (18-65 years old)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 5 weeks
Awards & highlights
Study Summary
This trial will study if a cable-actuated system can help people with cerebral palsy (CP) improve their locomotion and encourage them to be more independent.
Who is the study for?
This trial is for adults aged 18-65 with cerebral palsy who can walk at least 100 feet, even if they need help from devices. It's not for those with severe foot or knee deformities, recent surgery, pregnancy, lower limb prosthetics, serious lung or heart issues, loss of sensation in limbs, uncontrolled blood pressure, seizures or severe arthritis.Check my eligibility
What is being tested?
The study tests a new system that combines robotic gait training with auditory feedback to improve walking ability in people with CP. The goal is to extend the benefits of cable-actuated gait training and support self-care practices at home.See study design
What are the potential side effects?
Potential side effects may include discomfort from wearing the bodyweight augment system or smart insole and fatigue due to exercise during the use of these interventions. Specific side effects will depend on individual tolerance and physical condition.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can walk 100 feet with or without help like a cane.
Select...
I am an adult aged 18-65 with cerebral palsy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 5 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 5 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change of 10m walk between pre/post evaluation and 6 Training sessions
Change of 6 min walk between Pre/post evaluation
Change of Ground reaction force between 6 Training sessions
+2 moreOther outcome measures
Change of Muscle tone between Pre/post evaluation
Change of functional gait assessment between Pre/post evaluation
Change of strength of Post evaluation between Pre/post evaluation
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Adults with Cerebral PalsyExperimental Treatment2 Interventions
Adults with Cerebral Palsy who are able to be self-ambulatory for minimum 100 feet
Find a Location
Who is running the clinical trial?
State University of New York at BuffaloLead Sponsor
246 Previous Clinical Trials
49,483 Total Patients Enrolled
Jiyeon KangPrincipal InvestigatorUniversity at Buffalo
2 Previous Clinical Trials
128 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have not had surgery in the last 6 months.I use a prosthetic for my lower limb.I do not have severe respiratory, heart problems, loss of sensation, or uncontrolled blood pressure.I have a severe inward twist of my foot or backward bending of my knee.I can walk 100 feet with or without help like a cane.I have severe arthritis.I have a seizure disorder.I am an adult aged 18-65 with cerebral palsy.
Research Study Groups:
This trial has the following groups:- Group 1: Adults with Cerebral Palsy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this study open to participants under 2 decades of age?
"Adhering to the trial's requirements, participants should be aged 18 to 65 in order to qualify for enrollment."
Answered by AI
How many individuals are enrolled in this clinical investigation?
"Affirmative. The evidence on clinicaltrials.gov suggests that recruitment for this medical experiment is currently underway; it was initially posted on December 7th 2021 and most recently revised April 14th 2022, with 20 patients needed from 1 site."
Answered by AI
Is the recruitment of participants in this clinical trial still ongoing?
"Affirmative. Clinicaltrials.gov confirms that this medical trial, which was first posted on December 7th 2021 is actively searching for participants. Currently, 20 patients are being sought from one site to participate in the study."
Answered by AI
Who is eligible to enroll in this clinical investigation?
"The present medical trial necessitates that participants have a cerebral palsy diagnosis and be between 18 to 65 years old. It is estimated that they will accept up to 20 applicants in total."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger